These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31687869)

  • 1. Age-stratified analysis of serotype-specific baseline immunity against group B streptococcus.
    Choi MJ; Noh JY; Jang AY; Cheong HJ; Kim WJ; Song DJ; Cho GJ; Oh MJ; Zhi Y; Seo HS; Song JY
    Hum Vaccin Immunother; 2020 Jun; 16(6):1338-1344. PubMed ID: 31687869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women.
    Kwatra G; Adrian PV; Shiri T; Buchmann EJ; Cutland CL; Madhi SA
    Clin Microbiol Infect; 2015 Jun; 21(6):568.e13-21. PubMed ID: 25680313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of Opsonophagocytic Antibodies against Serotype Ia, Ib, II, III, and V Group B Streptococcus among Korean Population.
    Lee JH; Kim HW; Kim KH
    J Korean Med Sci; 2018 Apr; 33(16):e127. PubMed ID: 29651820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.
    Choi MJ; Noh JY; Cheong HJ; Kim WJ; Lin SM; Zhi Y; Lim JH; Lim S; Seo HS; Song JY
    Hum Vaccin Immunother; 2018 Jan; 14(1):67-73. PubMed ID: 28933634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonophagocytic Antibodies to Serotype Ia, Ib, and III Group B Streptococcus among Korean Infants and in Intravenous Immunoglobulin Products.
    Kim HW; Lee JH; Cho HK; Lee H; Seo HS; Lee S; Kim KH
    J Korean Med Sci; 2017 May; 32(5):737-743. PubMed ID: 28378545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Group B Streptococcus (GBS) Serum Serotype-Specific Anticapsular Immunoglobulin G Concentration and Risk Reduction for Invasive GBS Disease in South African Infants: An Observational Birth-Cohort, Matched Case-Control Study.
    Madhi SA; Izu A; Kwatra G; Jones S; Dangor Z; Wadula J; Moultrie A; Adam Y; Pu W; Henry O; Briner C; Cutland CL
    Clin Infect Dis; 2021 Sep; 73(5):e1170-e1180. PubMed ID: 33341870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.
    Carreras-Abad C; Cochet M; Hall T; Ramkhelawon L; Khalil A; Peregrine E; Vinayakarao L; Sivarajan S; Hamid R; Planche T; Sheridan E; Winchester S; Plumb J; Djennad A; Andrews N; Le Doare K; Heath P
    Health Technol Assess; 2019 Dec; 23(67):1-40. PubMed ID: 31855555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.
    Heyderman RS; Madhi SA; French N; Cutland C; Ngwira B; Kayambo D; Mboizi R; Koen A; Jose L; Olugbosi M; Wittke F; Slobod K; Dull PM
    Lancet Infect Dis; 2016 May; 16(5):546-555. PubMed ID: 26869376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.
    Madhi SA; Cutland CL; Jose L; Koen A; Govender N; Wittke F; Olugbosi M; Meulen AS; Baker S; Dull PM; Narasimhan V; Slobod K
    Lancet Infect Dis; 2016 Aug; 16(8):923-34. PubMed ID: 27139805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotype distribution and clinical correlation of Streptococcus agalactiae causing invasive disease in infants and children in Taiwan.
    Lo CW; Liu HC; Lee CC; Lin CL; Chen CL; Jeng MJ; Chiu CH
    J Microbiol Immunol Infect; 2019 Aug; 52(4):578-584. PubMed ID: 29100794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants.
    Dangor Z; Kwatra G; Izu A; Adrian P; Cutland CL; Velaphi S; Ballot D; Reubenson G; Zell ER; Lala SG; Madhi SA
    Vaccine; 2015 Nov; 33(48):6793-9. PubMed ID: 26478200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiological serotype and genotype distributions and clinical characteristics of group B streptococcus-inducing invasive disease among infants in South China.
    Zhu Y; Wu J; Zheng X; Liu D; Xu L; Chen D; Qiu W; Huang Z; Zhong R; Chen L; He M; Ma S; Lin Y; Lin X; Chen C
    BMC Pediatr; 2020 Apr; 20(1):146. PubMed ID: 32241251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
    Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
    Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of serotype V among infants with invasive group B streptococcal infections in South Korea.
    Yoon IA; Jo DS; Cho EY; Choi EH; Lee HJ; Lee H
    Int J Infect Dis; 2015 Sep; 38():136-40. PubMed ID: 26026823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women.
    Fabbrini M; Rigat F; Tuscano G; Chiarot E; Donders G; Devlieger R; Filippini S; Frigimelica E; Forte P; Wittke F; Halperin SA; Slobod K; Grandi G; Margarit I
    J Infect; 2018 May; 76(5):449-456. PubMed ID: 29374589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal dissemination of invasive and colonizing clonal complex 1 of serotype VI group B Streptococcus in central Taiwan.
    Lin HC; Chen CJ; Chiang KH; Yen TY; Ho CM; Hwang KP; Su BH; Lin HC; Li TC; Lu JJ
    J Microbiol Immunol Infect; 2016 Dec; 49(6):902-909. PubMed ID: 25560254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of type-specific group B streptococcal antibody in pregnant women.
    Vogel LC; Boyer KM; Gadzala CA; Gotoff SP
    J Pediatr; 1980 Jun; 96(6):1047-51. PubMed ID: 6989972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Microbiological Characteristics of Group B Streptococcus from Pregnant Women and Diseased Infants in Intrapartum Antibiotic Prophylaxis Era in Taiwan.
    Lee CC; Hsu JF; Prasad Janapatla R; Chen CL; Zhou YL; Lien R; Chiu CH
    Sci Rep; 2019 Sep; 9(1):13525. PubMed ID: 31537886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infant serotype specific anti-capsular immunoglobulin G antibody and risk of invasive group B Streptococcal disease.
    Dangor Z; Kwatra G; Izu A; Khan M; Lala SG; Madhi SA
    Vaccine; 2021 Nov; 39(47):6813-6816. PubMed ID: 34688499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4-6 Years After a First Dose: Results From a Phase 2 Trial.
    Leroux-Roels G; Bebia Z; Maes C; Aerssens A; De Boever F; Grassano L; Buffi G; Margarit I; Karsten A; Cho S; Slobod K; Corsaro B; Henry O
    Clin Infect Dis; 2020 Jun; 70(12):2570-2579. PubMed ID: 31394574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.